In March 2017, the NHS England Board set out its strategic approach to build a National Genomic Medicine Service.

The UK is recognised internationally as a leader in genomics and the unique structure of the NHS supports the delivery of advances at scale and pace for patient benefit.


The National Genomic Medicine Service enables a quicker diagnosis for patients with a rare disease saving lives.


Matching people to the most effective medications and interventions, reducing the likelihood of an adverse drug reaction.


Increasing the number of people surviving cancer each year through accurate and early diagnosis, and effective use of personalised therapies.

“The NHS will be the world-leading healthcare system in its use of cutting edge genomic technologies to predict and diagnose inherited and acquired disease, and to personalise treatments and interventions.”

Learn More

Latest News & Events

News & Events